TrialAnnals of clinical and translational neurology2024

Subcutaneous batoclimab in generalized myasthenia gravis: Results from a Phase 2a trial with an open-label extension.

Richard J Nowak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.